Please assess the completion status of the following clinical trial:

Trial Title: Pravastatin or Atorvastatin Evaluation and Infection Therapy (TIMI22)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Hospitalization for MI or high risk unstable angina within the last 10 days.~* Total cholesterol 240 mg/dl or greater.~* Stabilized post ACS~Exclusion Criteria:~* Co-morbidity with life expectations no more than 2 years.~* Current lipid lowering therapy~* Corrected QT interval~* Need for Class IA or III antiarrhythmic agent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).